LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING A PEGYLATED HUMAN ERYTHROPOIETIN PROTEIN AND A MULTIPLE CHARGED INORGANIC ANION, IN A PHARMACEUTICALLY ACCEPTABLE BUFFER

摘要

The present invention relates to a liquid pharmaceutical composition consisting essentially of an erythropoietin protein, a multiple charged inorganic anion in a pharmaceutically acceptable buffer suitable to keep the solution pH in the range from about 5.5 to about 7.0, and optionally one or more pharmaceutically acceptable excipients. This composition is especially useful for the prophylaxis and treatment of diseases related to erythropoiesis.